/Companies

Noninvasix Medical Devices

Galveston, US · 7 known investors

Find your way into Noninvasix Medical Devices

Sign up to see every warm intro you have to Noninvasix Medical Devices

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Noninvasix Medical Devices team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Noninvasix develops a patented optoacoustic platform that non-invasively and continuously measures central venous oxygen saturation to help ICU clinicians diagnose and monitor tissue hypoxia in sepsis and septic shock patients in real time. The technology is aimed at critical care settings, with planned applications in fetal monitoring, neonatal care, traumatic brain injury, and blood loss.

Founders & leadership

DP
Donald ProughClinical Vice PresidentDonald Prough holds a Clinical Vice President role at Noninvasix Medical Devices. He has backgrounds in anesthesiology education, critical care medicine, medical research focused on traumatic brain injury, and medical device development.
GL
Graham L. RandallExecutive
DJDavid J. Giarracco
David J. GiarraccoChief Executive OfficerDavid J. Giarracco is Chief Executive Officer of Noninvasix Medical Devices, which develops an optoacoustic platform for non-invasive continuous measurement of central venous oxygen saturation in critical care settings.
TLThomas Luby
Thomas LubyNamed on SEC filingPhD at TMC Venture Fund
ML
Michael LoweNamed on SEC filing

Investors · 7

Also in the syndicate · 1

Texas Medical Center Venture Fundlead

Funding

SEC filings, press & company announcements

$4M disclosed across 1 of 2 rounds · 2020–2021

▶$4MraisedJun 2020 · 18 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas LubyDirector
  • Graham L. RandallExecutive Officer, Director
  • Donald S. ProughExecutive Officer, Director
  • Michael LoweDirector
Offering amount
$4M
Amount sold
$4M
First sale
Mar 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Noninvasix Medical Devices do?
Noninvasix develops a patented optoacoustic platform that non-invasively and continuously measures central venous oxygen saturation to help ICU clinicians diagnose and monitor tissue hypoxia in sepsis and septic shock patients in real time. The technology is aimed at critical care settings, with planned applications in fetal monitoring, neonatal care, traumatic brain injury, and blood loss.
Who founded Noninvasix Medical Devices?
Noninvasix Medical Devices was founded by Donald Prough.
Who are Noninvasix Medical Devices's investors?
Noninvasix Medical Devices's investors include Green Park & Golf Ventures, Health Wildcatters, Rockies Venture Club, Texas Ventures, TMC Venture Fund, Philips Ventures.
How much funding has Noninvasix Medical Devices raised?
Noninvasix Medical Devices has disclosed $4M raised across 1 of its 2 known rounds.
Where is Noninvasix Medical Devices headquartered?
Noninvasix Medical Devices is headquartered in Galveston, US.